Diagnosing lysosomal storage disorders: mucopolysaccharidosis type II.

Britt A. Johnson, Otto P. van Diggelen, Angela Dajnoki, Olaf A. Bodamer

Research output: Contribution to journalArticlepeer-review

Abstract

Mucopolysaccharidosis type II (MPS II) is an X-linked lysosomal storage disorder caused by a deficiency of iduronate 2-sulfatase (IDS). Progressive, intralysosomal accumulation of the glycosaminoglycans (GAGs) dermatan and heparan sulfate in almost all tissues leads to multi-organ involvement in affected males but to virtual absence of symptoms in heterozygote female carriers due to preferential inactivation of the mutant allele. Diagnosis of MPS II in males is based on IDS analysis in leukocytes, fibroblasts, plasma, or dried blood spots (DBS), whereas IDS activities may be within the normal range in heterozygote females. The advent of fluorometric and mass spectrometry methods for enzyme analysis in DBS has simplified the diagnostic approach for MPS II males. Molecular analysis of the IDS gene confirms the diagnosis of MPS II in males and is the only diagnostic test to confirm carrier status in females. This unit provides detailed analytical protocols for measurement of IDS activity in DBS and plasma using a fluorometric assay.

Original languageEnglish
JournalCurrent protocols in human genetics / editorial board, Jonathan L. Haines ... [et al.]
Volume79
StatePublished - Jan 1 2013

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Diagnosing lysosomal storage disorders: mucopolysaccharidosis type II.'. Together they form a unique fingerprint.

Cite this